Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis⦠read more
Healthcare
Medical Instruments & Supplies
22 years
USD
Exclusive to Premium users
$0.44
Price+1.41%
$0.00
$19.803m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$88.750m
-
1y CAGR-
3y CAGR-
5y CAGR-$57.406m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.30
-
1y CAGR-
3y CAGR-
5y CAGR$15.733m
$80.093m
Assets$64.360m
Liabilities$43.314m
Debt54.1%
-0.9x
Debt to EBITDA$4.920m
-
1y CAGR-
3y CAGR-
5y CAGR